5.35
Schlusskurs vom Vortag:
$5.41
Offen:
$5.37
24-Stunden-Volumen:
240.90K
Relative Volume:
1.00
Marktkapitalisierung:
$332.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-76.41M
KGV:
-2.7865
EPS:
-1.92
Netto-Cashflow:
$-64.56M
1W Leistung:
-12.72%
1M Leistung:
-7.12%
6M Leistung:
+7.65%
1J Leistung:
-51.19%
Aura Biosciences Inc Stock (AURA) Company Profile
Firmenname
Aura Biosciences Inc
Sektor
Branche
Telefon
(617)500-8864
Adresse
80 GUEST STREET, BOSTON
Vergleichen Sie AURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
AURA
Aura Biosciences Inc
|
5.35 | 336.07M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2022-07-19 | Eingeleitet | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Aktie (AURA) Neueste Nachrichten
Is it time to cut losses on Aura Biosciences Inc.July 2025 Closing Moves & Low Risk Investment Opportunities - newser.com
Volume spikes in Aura Biosciences Inc. stock – what they mean2025 Geopolitical Influence & Stepwise Swing Trade Plans - newser.com
Aura Biosciences Inc. stock trend forecastPortfolio Update Report & Community Trade Idea Sharing Platform - newser.com
How Aura Biosciences Inc. stock performs after earningsNew Guidance & Breakout Confirmation Trade Signals - newser.com
Published on: 2025-11-06 22:35:11 - newser.com
Aura Biosciences Inc. stock outlook for YEARWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com
Can you recover from losses in Aura Biosciences Inc.Market Performance Summary & AI Powered Market Entry Ideas - newser.com
Why Aura Biosciences Inc. stock appeals to dividend seekers2025 Historical Comparison & Expert Verified Movement Alerts - fcp.pa.gov.br
Will Aura Biosciences Inc. stock split again soonJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
Published on: 2025-11-05 04:20:25 - newser.com
Using fundamentals and technicals on Aura Biosciences Inc.2025 Price Targets & Safe Entry Zone Tips - newser.com
Applying big data sentiment scoring on Aura Biosciences Inc.2025 Technical Overview & Reliable Breakout Forecasts - newser.com
How Aura Biosciences Inc. stock performs in weak economyWeekly Gains Summary & Long Hold Capital Preservation Plans - newser.com
Is Aura Biosciences Inc. stock cheap compared to fundamentalsDip Buying & Long-Term Capital Growth Strategies - newser.com
How to build a dashboard for Aura Biosciences Inc. stockJuly 2025 Retail & Safe Capital Investment Plans - newser.com
Liquidity Mapping Around (AURA) Price Events - news.stocktradersdaily.com
Published on: 2025-11-04 00:27:04 - newser.com
How analysts rate Aura Biosciences Inc. stock todayQuarterly Earnings Summary & Reliable Momentum Entry Alerts - newser.com
What drives Aura Biosciences Inc stock priceGap Up/Gap Down Analysis & Get Free Training on Technical Indicators - earlytimes.in
Real time pattern detection on Aura Biosciences Inc. stockTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Should you hold or exit Aura Biosciences Inc. nowJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
Aura Biosciences CEO Makes Significant Stock Sale! - TipRanks
Aura Biosciences Director Elisabet de los Pinos Sells Shares to Cover Tax Obligations - TradingView
Form 4: AURA officer automatic sale of 896 shares to cover taxes - Stock Titan
[Form 4] Aura Biosciences, Inc. Insider Trading Activity - Stock Titan
Aura Biosciences’ Phase 3 Trial: A Potential Game-Changer in Ocular Melanoma Treatment - TipRanks
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Is Aura Biosciences Inc. stock trading near support levelsEarnings Trend Report & Safe Swing Trade Setups - Fundação Cultural do Pará
Finanzdaten der Aura Biosciences Inc-Aktie (AURA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):